Tenaya Therapeutics (TNYA) Revenue & Revenue Breakdown
Tenaya Therapeutics Revenue Highlights
00
Tenaya Therapeutics Revenue by Period
Tenaya Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Tenaya Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $17.66M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Tenaya Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
OCUL | Ocular Therapeutix | $58.44M | $14.71M |
BCYC | Bicycle Therapeutics | $26.98M | $2.68M |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
IGMS | IGM Biosciences | $2.13M | $516.00K |
EYEN | Eyenovia | $3.79K | $1.63K |
CRVS | Corvus Pharmaceuticals | - | - |
AKRO | Akero Therapeutics | - | - |
ALXO | ALX Oncology | - | - |
GOSS | Gossamer Bio | - | $9.48M |
VINC | Vincerx Pharma | - | - |
INZY | Inozyme Pharma | - | - |
TNYA | Tenaya Therapeutics | - | - |
RANI | Rani Therapeutics | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
DRTS | Alpha Tau Medical | - | - |
BMEA | Biomea Fusion | - | - |